Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
We identified microRNA, miR186-5p which suppress the expression of histone de-methylase JMJD3 with enzyme activity opposite to EZH2. We confirmed that the suppression of JMJD3, CDH1, VASH1, and TFAP2E by the over-expression of miR186-5p in colon cancer cell line. We confirmed that cisplatin sensitivity was increased when I controlled expression of histone methylase EZH2 in colon cancer cell line.
|